Medicines / Companies / Eli Lilly and Company (India)
Eli Lilly and Company (India)What it sells in India.
Eli Lilly and Company (India) has 31 packs of 13 brands on NPPA's price list for July 2026, across 12 molecules and combinations.
- Packs
- 31
- Brands
- 13
- Molecules
- 12
- Price-controlled packs
- 2
- Failed batches named
- 0
Largest molecules
- Tirzepatide8 packs
- Abemaciclib4 packs
- Insulin Devices2 packs
- Somatostatin2 packs
- Gemcitabine2 packs
- Pemetrexed2 packs
- Ramucirumab2 packs
- Baricitinib2 packs
- Teriparatide2 packs
- Selpercatinib2 packs
- Unclassified Molecules2 packs
- Human Premix Insulin1 pack
Brands
Batches declared not of standard quality
No CDSCO alert in the record names this company as the manufacturer. Alerts name the plant that made a batch, which is often a contract manufacturer and not the marketer.
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.